Human Liver Models Market by Drug Discovery Platform (Liver-on-a-chip, Non-alcoholic Fatty Liver Organoids, 2D Models, Animal Models, 3D Bioprinting), and Region (North America, Europe, Asia Pacific, Rest of the World) – 2020 to 2025

$3,850.00$5,850.00

Published on: March 23, 2020
Clear
SKU: GMS-2096 Category: Tag:

The global market for human liver models is expected to hit USD 4.23 billion by 2025, rising over the forecast period at a CAGR of 11.91%. The growth of this market is driven primarily by factors such as the rising emphasis on developing alternatives for animal testing models, a substantial increase in research funding and investment in venture capital for the production of liver models, the initiatives to raise awareness of liver organoids, raising the prevalence of non-alcoholic fatty liver disease and raising ear need

Human Liver Models Market by Drug Discovery Platform (Liver-on-a-chip, Non-alcoholic Fatty Liver Organoids, 2D Models, Animal Models, 3D Bioprinting), and Region (North America, Europe, Asia Pacific, Rest of the World) - 2020 to 2025 1

Human Liver Models Market by Drug Discovery Platform (Liver-on-a-chip, Non-alcoholic Fatty Liver Organoids, 2D Models, Animal Models, 3D Bioprinting), and Region (North America, Europe, Asia Pacific, Rest of the World) - 2020 to 2025 2

Human Liver Models Market by Drug Discovery Platform (Liver-on-a-chip, Non-alcoholic Fatty Liver Organoids, 2D Models, Animal Models, 3D Bioprinting), and Region (North America, Europe, Asia Pacific, Rest of the World) - 2020 to 2025 3

Human Liver Models Market by Drug Discovery Platform (Liver-on-a-chip, Non-alcoholic Fatty Liver Organoids, 2D Models, Animal Models, 3D Bioprinting), and Region (North America, Europe, Asia Pacific, Rest of the World) - 2020 to 2025 4

Human Liver Models Market by Drug Discovery Platform (Liver-on-a-chip, Non-alcoholic Fatty Liver Organoids, 2D Models, Animal Models, 3D Bioprinting), and Region (North America, Europe, Asia Pacific, Rest of the World) - 2020 to 2025 5

Human Liver Models Market by Drug Discovery Platform (Liver-on-a-chip, Non-alcoholic Fatty Liver Organoids, 2D Models, Animal Models, 3D Bioprinting), and Region (North America, Europe, Asia Pacific, Rest of the World) - 2020 to 2025 6

Human Liver Models Market by Drug Discovery Platform (Liver-on-a-chip, Non-alcoholic Fatty Liver Organoids, 2D Models, Animal Models, 3D Bioprinting), and Region (North America, Europe, Asia Pacific, Rest of the World) - 2020 to 2025 7

Human Liver Models Market by Drug Discovery Platform (Liver-on-a-chip, Non-alcoholic Fatty Liver Organoids, 2D Models, Animal Models, 3D Bioprinting), and Region (North America, Europe, Asia Pacific, Rest of the World) - 2020 to 2025 8

1 Global Human Liver Models Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Human Liver Models Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Human Liver Models Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Human Liver Models Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Human Liver Models Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Human Liver Models Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Human Liver Models Market – By Drug Discovery Platform (Market Size – &
million/billion)
8.1 Liver Organoids
8.2 Liver-on-a-chip
8.3 2D Models
8.4 Animal Models
8.5 3D Bioprinting

9 Global Human Liver Models Market – By Geography (Market Size – & million/billion)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 U.K
9.3.2 Germany
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia-Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 South Korea
9.4.5 Rest of APAC
9.5 Rest of the World
9.5.1 South America
9.5.2 Middle East
9.5.3 Africa

10 Global Human Liver Models Market – Entropy
10.1 New product launches
10.2 M&A’s, collaborations, JVs and partnerships

11 Global Human Liver Models Market Company Profile (Key Players)
11.1 Market Share, Company Revenue, Products, M&A, Developments
11.2 Emulate
11.3 Ascendance Bio
11.4 HìREL
11.5 CN Bio
11.6 Organovo
11.7 Cyfuse Biomedical
11.8 Company 7
11.9 Company 8
11.10 Company 9
11.11 Company 10
11.12 Company 11 & more

12 Global Human Liver Models Market – Appendix
12.1 Sources
12.2 Abbreviations